EBD Group is part of the KNect365 of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy
Share/Follow Us
Share this:
Follow this event:
Subscribe to our newsletters:

Partnerships in Cell and Gene Therapies Press Releases

partnering360:Insight Latest headlines from partnering360:Insight

October 10, 2016 Denmark-based biotech Curasight making strides in cancer therapies CSO and Co-Founder of Curasight Andreas Kjaer describes his company's efforts to develop novel, innovative radionuclide therapies for cancer, while raising its profile outside of Denmark. more ►

October 7, 2016 Rentschler maintains continuity while positioning for further growth A leading contract manufacturing organization for the development of biopharmaceuticals, keeping pace with growth has become the full-time focus at Rentschler Biotechnologie. Dr. Mathias spoke with partneringNEWS about opportunities moving forward as he shapes the strategic direction for the group. more ►

October 7, 2016 Kura Oncology develops drug therapy for HRAS mutation cancers Kura Oncology CEO Troy Wilson spoke about his company's precision medicine approach to treating cancer. Its most advanced drug candidate, tipifarnib showed promising clinical activity in a Phase II trial. more ►

October 6, 2016 CureDuchenne: The Mom Filter scores three profitable exits, one FDA approval Debra Miller takes drug development very seriously when it has anything to do with Duchenne muscular dystrophy. And if you want to learn how passion and persistence can pay off, you will want to hear her speak during the BIO-Europe® session, "An autobahn for rare drug development," on November 7, 2016 in Cologne, Germany. more ►

October 5, 2016 Omada Health merges technology and medicine in the clinic to treat chronic diseases When technology and medicine combine, organizations that merge deep technology, deep pharma and deep clinical work are bound to emerge. Leading the pack are companies like Omada. more ►

Arrow Up

Follow this event:
Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD Group
Privacy Policy and Cookies
Terms of Use